Timeslot: Wednesday, April 21, 2021 - 3:15pm to 4:45pm
Track: Therapeutic Delivery
The mission of the Nanomaterials SIG is to advocate for and organize the exchange of ideas involving the unique science and technology present in biomaterials at the nanoscale. By focusing on science, the SIG will champion the continual push to uncover new knowledge at the nanoscale and connect this to macroscale properties and behaviors of biomaterials. Through its focus on technology, the SIG will foster innovative design and synthesis of nanobiomaterials useful in the creation of new and better devices, diagnostics and therapeutics for biomedical applications. The SIG emphasizes an interdisciplinary vision to facilitate the translation of nanomaterials to achieve intended biological significance and medical impact. The vision is to establish the NanoSIG to become a thought leader in the nanobiomaterials research community by emphasizing nanoscience discovery, nanotechnology application, and clinical translation innovation.
Ming Su, PhD
Abstracts will be available for download on April 20, 2021.
103. Sustained & Localized Cyclosporine Delivery and Activity Using Nanomicelles and Nanofibrils, Diana Velluto, PhD, Damir Bojadzic, Teresa De Toni, Peter Buchwald, PhD, Alice Tomei, PhDUniversity of Miami, Miami, FL, USA
104. Application of Magnetic Particle Imaging Technology to Understand Nanoparticle Biodistribution in Osteoarthritic Joints, Tolulope AjayiUniversity of Florida, Gainesville, FL, USA
105. Dual-Nanoparticle System for Enhanced Drug Accumulation and Prolonged Retention in Metastatic Cancers, Michaela Prado1,2,3, Pere Dosta, PhD1,2, Pau Hurtado, MSc1,2, Natalie Artzi, PhD1,21Brigham and Womenâ€™s Hospital, Harvard Medical School, Boston, MA, USA, 2Massachusetts Institute of Technology, Cambridge, MA, USA, 3TecnolÃ³gico de Monterrey, Monterrey, Mexico
107. Protein corona formed on nanoparticles is sensitive to isomeric differences in surface chemistry, Sridevi Baradhwaj Conjeevaram, Ryan BlanchardTexas A&M University, College Station, TX, USA
108. Targeting Scavenger Receptor Type B1 and Cellular Cholesterol with High-Density Lipoprotein Mimetic Nanoparticles Inhibits SARS-CoV-2 Infection, Stephen Henrich, Kaylin McMahon, PhD, Nicole Palacio, Pablo Penaloza-McMaster, PhD, Colby Thaxton, MD, PhDNorthwestern University, Chicago, IL, USA